| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.13▲ | 10.05▲ | 10.07▲ | 10.05▲ | 9.38▲ |
| MA10 | 10.07▲ | 10.04▲ | 9.99▲ | 9.89▲ | 9.14▲ |
| MA20 | 10.06▲ | 9.96▲ | 10.04▲ | 9.32▲ | 7.50▲ |
| MA50 | 10.04▲ | 10.05▲ | 9.96▲ | 9.00▲ | 4.66▲ |
| MA100 | 9.98▲ | 9.93▲ | 9.53▲ | 7.24▲ | 3.29▲ |
| MA200 | 10.03▲ | 9.49▲ | 9.45▲ | 4.99▲ | 2.98▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.016▲ | 0.017▲ | 0.004▲ | 0.052▲ | 0.159▲ |
| RSI | 61.506▲ | 56.780▲ | 54.908▲ | 57.803▲ | 70.667▲ |
| STOCH | 85.968▲ | 53.130 | 64.235 | 80.246▲ | 59.492 |
| WILL %R | -24.074▲ | -19.355▲ | -19.048▲ | -15.385▲ | -20.225▲ |
| CCI | 119.728▲ | 128.124▲ | 108.035▲ | 85.326 | 88.963 |
|
Thursday, April 09, 2026 05:52 AM
Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will participate and host institutional investor ...
|
|
Monday, March 30, 2026 06:00 AM
NEXICART-2 (NCT06097832) is a multi-site U.S. Phase 2 clinical trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory AL Amyloidosis, with a registrational design. NEXICART-2 is a ...
|
|
Wednesday, March 25, 2026 01:20 PM
I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Immix Biopharma (IMMX). The reason why I want to go over this biotech next is because it is ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/04/26 | 9.91 | 10.3199 | 9.81 | 10.18 | 583,552 |
| 21/04/26 | 10.08 | 10.1899 | 9.55 | 9.68 | 1,554,457 |
| 20/04/26 | 10.29 | 10.35 | 9.8712 | 10.09 | 568,432 |
| 17/04/26 | 10.10 | 10.5291 | 9.51 | 10.35 | 1,043,420 |
| 16/04/26 | 10.05 | 10.07 | 9.26 | 9.96 | 737,942 |
| 15/04/26 | 9.84 | 10.16 | 9.73 | 10.04 | 614,445 |
| 14/04/26 | 9.79 | 10.09 | 9.685 | 9.85 | 508,798 |
| 13/04/26 | 9.4823 | 10.155 | 9.2351 | 9.69 | 601,473 |
| 10/04/26 | 9.78 | 9.96 | 9.12 | 9.26 | 399,412 |
| 09/04/26 | 8.75 | 10.07 | 8.72 | 9.75 | 935,360 |
|
|
||||
|
|
||||
|
|